Erleada 60 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F1X86
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,966
Award facts
- Contract value 100% obligated
- $7,965.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,965.80 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120 count) on January 27, 2026, with an ultimate completion date of February 18, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania location. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains for military and veteran healthcare systems. This particular delivery order for Erleada, a prescription oncology medication, reflects the company's ongoing role in supplying specialty medications to support the Defense Health Agency and other government healthcare customers through its established prime vendor relationship with DLA.
Quick answers
Who was awarded contract SPE2DR26F1X86?
SPE2DR26F1X86 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F1X86 worth?
The government has obligated $7,966 on SPE2DR26F1X86.
Is contract SPE2DR26F1X86 an order under another contract?
Yes. SPE2DR26F1X86 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1X86 competed?
The extent of competition for SPE2DR26F1X86 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award